EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analytical validation of protein biomarkers for risk of spontaneous preterm birth

Chad Bradford, Rob Severinsen, Trina Pugmire, Matison Rasmussen, Kathryn Stoddard, Yuta Uemura, Spencer Wheelwright, Marija Mentinova, Daniel Chelsky, Stephen W Hunsucker, Paul Kearney, Durlin Hickok und 5 weitere

Clinical Mass Spectrometry · 2017

DOI: 10.1016/j.clinms.2017.06.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Mass Spectrometry, 2017. Verfasst von Chad Bradford und 16 weiteren Autor:innen. Beteiligte Einrichtung: Sera Prognostics, Inc., 2749 East Parleys Way, Suite 200, Salt Lake City, UT 84109, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Presented are the validation results of a second-generation assay for determining the relative abundances of two protein biomarkers found in maternal serum that predict an individual's risk of spontaneous preterm birth. The sample preparation workflow is complex, consisting of immuno-depletion of high-abundance serum proteins, tryptic digestion of the immuno-depleted fraction to generate surrogate peptide analytes, and detection by tandem mass spectrometry. The method was determined to be robust on observation of the following characteristics: classifier peptide detection precision was excellent; results were accurate when compared to a reference method; results were linear over a clinically relevant range; the limits of quantitation encompassed the range of expected results; and the method demonstrated analytical specificity and resilience to differences in patient serum and common endogenous interferents.

Schlagwörter

Stichwörter der Autor:innen

ClinicalInsulin-like growth factor-binding protein 4Mass spectrometryProteomicsSex hormone-binding globulinSpontaneous preterm birthValidation

Autor:innen und Institutionen

  • Sera Prognostics, Inc., 2749 East Parleys Way, Suite 200, Salt Lake City, UT 84109, USA.
  • Caprion Biosciences, 201 Avenue Président Kennedy, Suite 3900, Montréal, Québec H2X 3Y7, Canada.
  • Integrated Diagnostics, Inc., 219 Terry Avenue North, Suite 110, Seattle, WA 98101, USA.

Zitieren

APA

Bradford, C., Severinsen, R., Pugmire, T., Rasmussen, M., Stoddard, K., Uemura, Y., Wheelwright, S., Mentinova, M., Chelsky, D., Hunsucker, S. W., Kearney, P., Hickok, D., Fleischer, T. C., Ichetovkin, I., Boniface, J. J., Critchfield, G. C., & Peltier, J. M. (2017). Analytical validation of protein biomarkers for risk of spontaneous preterm birth. Clinical Mass Spectrometry. https://doi.org/10.1016/j.clinms.2017.06.002

Vancouver

Bradford C, Severinsen R, Pugmire T, Rasmussen M, Stoddard K, Uemura Y, et al. Analytical validation of protein biomarkers for risk of spontaneous preterm birth. Clinical Mass Spectrometry. 2017. doi:10.1016/j.clinms.2017.06.002

BibTeX
@article{Bradford2017,
  author = {Bradford, Chad and Severinsen, Rob and Pugmire, Trina and Rasmussen, Matison and Stoddard, Kathryn and Uemura, Yuta and Wheelwright, Spencer and Mentinova, Marija and Chelsky, Daniel and Hunsucker, Stephen W and Kearney, Paul and Hickok, Durlin and Fleischer, Tracey C and Ichetovkin, Ilia and Boniface, J Jay and Critchfield, Gregory C and Peltier, John M},
  title = {Analytical validation of protein biomarkers for risk of spontaneous preterm birth},
  journal = {Clinical Mass Spectrometry},
  year = {2017},
  doi = {10.1016/j.clinms.2017.06.002}
}
Kostenlos starten →